{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:24:16Z","timestamp":1771550656839,"version":"3.50.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background\/Objective<\/jats:title>\n<jats:p>Despite multiple attempts, no surrogate biomarker of Parkinson disease (PD) has been definitively identified. Alternatively, identifying a non-invasive biomarker is crucial to understanding the natural history, severity, and progression of PD and to guide future therapeutic trials. Recent work highlighted alpha synuclein-containing extracellular vesicles and Poly (ADP-ribose) polymerase (PARP-1) activity as drivers of PD pathogenesis and putative PD biomarkers. This exploratory study evaluated the role of alpha-synuclein-positive extracellular vesicles and PARP-1 activity in the plasma of PD patients as non-invasive markers of the disease\u2019s severity and progression.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We collected plasma of 57 PD patients (discovery cohort 20, replication cohort 37) and compared it with 20 unaffected individuals, 20 individuals with clinically diagnosed Alzheimer\u2019s disease, and 20 individuals with dementia with Lewy bodies. We analyzed alpha-synuclein-positive extracellular vesicles from platelet-free plasma by nanoscale flow cytometry and blood concentrations of poly ADP-ribose using sandwich ELISA kits.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Median concentration of \u03b1-synuclein extracellular vesicles was significantly higher in PD patients compared to the other groups (Kruskal-Wallis, p &lt; .0001). In the discovery cohort, patients with higher \u03b1-synuclein extracellular vesicles had a higher Unified Parkinson Disease Rating Scale score (UPDRS III median = 22 vs. 5, p = 0.045). Seven out of 20 patients (35%) showed detectable PAR levels, with positive patients showing significantly higher levels of \u03b1-synuclein extracellular vesicles. In the replication cohort, we did not observe a significant difference in the PAR-positive cases in relationship with UPDRS III.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Non-invasive determination of \u03b1-synuclein-positive extracellular vesicles may provide a potential non-invasive marker of PD disease severity, and longitudinal studies are needed to evaluate the role of \u03b1-synuclein-positive extracellular vesicles as a marker of disease progression.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0264446","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T17:24:25Z","timestamp":1649438665000},"page":"e0264446","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Poly (ADP-Ribose) and \u03b1\u2013synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity"],"prefix":"10.1371","volume":"17","author":[{"given":"Fabrice","family":"Lucien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo E.","family":"Benarroch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farwa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-1185","authenticated-orcid":true,"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-0261","authenticated-orcid":true,"given":"Cole","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Camerucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-0627","authenticated-orcid":true,"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"issue":"2","key":"pone.0264446.ref001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ane.12247","article-title":"Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson\u2019s disease\u2014a systematic review","volume":"130","author":"N Malek","year":"2014","journal-title":"Acta neurologica Scandinavica"},{"issue":"6645","key":"pone.0264446.ref002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"issue":"2","key":"pone.0264446.ref003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"H Braak","year":"2003","journal-title":"Neurobiology of aging"},{"issue":"5","key":"pone.0264446.ref004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11910-015-0549-x","article-title":"The prion hypothesis of Parkinson\u2019s disease","volume":"15","author":"Y Chu","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"pone.0264446.ref005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"H Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"pone.0264446.ref006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2014.07.003","article-title":"A cell culture model for monitoring alpha-synuclein cell-to-cell transfer","volume":"77","author":"JF Reyes","year":"2015","journal-title":"Neurobiol Dis"},{"key":"pone.0264446.ref007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"KM Danzer","year":"2012","journal-title":"Mol Neurodegener"},{"issue":"7","key":"pone.0264446.ref008","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","article-title":"Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases","volume":"92","author":"AJ Espay","year":"2019","journal-title":"Neurology"},{"issue":"6414","key":"pone.0264446.ref009","article-title":"Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"TI Kam","year":"2018","journal-title":"Science"},{"issue":"48","key":"pone.0264446.ref010","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"SA Andrabi","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"pone.0264446.ref011","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1055\/s-0038-1668544","article-title":"Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity","volume":"118","author":"J Gomes","year":"2018","journal-title":"Thromb Haemost"},{"issue":"3","key":"pone.0264446.ref012","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"AJ Hughes","year":"1992","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"31","key":"pone.0264446.ref013","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"P Desplats","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"pone.0264446.ref014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-017-0445-5","article-title":"Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology","volume":"5","author":"J Ngolab","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"pone.0264446.ref015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2018.11.002","article-title":"Portrait of blood-derived extracellular vesicles in patients with Parkinson\u2019s disease","volume":"124","author":"J Lamontagne-Proulx","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"4","key":"pone.0264446.ref016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/08923973.2019.1650371","article-title":"The multiple roles of exosomes in Parkinson\u2019s disease: an overview","volume":"41","author":"C Porro","year":"2019","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"pone.0264446.ref017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/ene.14208","article-title":"A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson\u2019s disease development and progression","volume":"27","author":"M Niu","year":"2020","journal-title":"Eur J Neurol"},{"issue":"5","key":"pone.0264446.ref018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"M Shi","year":"2014","journal-title":"Acta neuropathologica"},{"key":"pone.0264446.ref019","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and alpha-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson\u2019s Disease","volume":"10","author":"ZH Zhao","year":"2018","journal-title":"Frontiers in aging neuroscience"},{"issue":"2","key":"pone.0264446.ref020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pjnns.2017.11.009","article-title":"The relation between plasma alpha-synuclein level and clinical symptoms or signs of Parkinson\u2019s disease","volume":"52","author":"M Malec-Litwinowicz","year":"2018","journal-title":"Neurol Neurochir Pol"},{"issue":"11","key":"pone.0264446.ref021","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.28639","article-title":"alpha-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson\u2019s Disease","volume":"36","author":"A Stuendl","year":"2021","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"pone.0264446.ref022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","article-title":"Investigation of alpha-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated alpha-Synuclein as Potential Peripheral Biomarker of Parkinson\u2019s Disease","volume":"469","author":"H Zheng","year":"2021","journal-title":"Neuroscience"},{"issue":"7","key":"pone.0264446.ref023","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism","volume":"91","author":"C Jiang","year":"2020","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"1","key":"pone.0264446.ref024","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1038\/s41598-019-49668-y","article-title":"Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients","volume":"9","author":"A Gamez-Valero","year":"2019","journal-title":"Scientific reports"},{"issue":"2","key":"pone.0264446.ref025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"R Barbour","year":"2008","journal-title":"Neuro-degenerative diseases"},{"issue":"8","key":"pone.0264446.ref026","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10571-018-0622-5","article-title":"Secretion and Uptake of alpha-Synuclein Via Extracellular Vesicles in Cultured Cells","volume":"38","author":"G Gustafsson","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"pone.0264446.ref027","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","journal-title":"Nature communications"},{"issue":"5","key":"pone.0264446.ref028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"JS Park","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"pone.0264446.ref029","doi-asserted-by":"crossref","first-page":"639646","DOI":"10.3389\/fnins.2021.639646","article-title":"Inflammatory Responses to Monomeric and Aggregated alpha-Synuclein in Peripheral Blood of Parkinson Disease Patients","volume":"15","author":"F Piancone","year":"2021","journal-title":"Frontiers in neuroscience"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T17:24:48Z","timestamp":1649438688000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264446"}},"subtitle":[],"editor":[{"given":"Ted M","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0264446","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]}}}